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ﺔﯿﻟﻮﺒﻟا يرﺎﺠﻤﻟا بﺎﮭﺘﻟﺎﺑ ﻦﯿﺑﺎﺼﻤﻟا ﻰﺿﺮﻤﻟا ﻦﻣ ﻼﯿﺴﺒﻠﻜﻟاو ﺔﯾﻮﻌﻤﻟا نﻮﻟﻮﻘﻟا ﺎﯾﺮﺘﻜﺑ لﺰﻋ
Kawther Adnan Hassan/ M.SC. Microbiology(pathogen bacteriology)
University of Kufa (Faculty of Nursing) Department of Basic Medical Sciences
ﺔﺻﻼﺨﻟا:
ﺔﯿﻔﻠﺨﻟا:ﺔﯿﻟﻮﺒﻟا يرﺎﺠﻤﻟا بﺎﮭﺘﻟا ﺔﺠﻟﺎﻌﻣ ﻲﻓ أﺪﯿﻘﻌﺗ ﺐﺒﺴﺗ ﺔﯾﻮﯿﺤﻟا تادﺎﻀﻤﻠﻟ ﻼﯿﺴﺒﻠﻜﻟاو ﺔﯾﻮﻌﻤﻟا نﻮﻟﻮﻘﻟا ﺎﯾﺮﺘﻜﺑ ﺔﻣوﺎﻘﻣ.
فﺪﮭﻟا :نايرﺎﺠﻤﻟا بﺎﮭﺘﻟﻻ ﺔﺒﺒﺴﻤﻟا ﺎﯾﺮﺘﻜﺒﻟا ﺪﺿ يﻮﯿﺤﻟا دﺎﻀﻤﻟا ﺔﯿﻟﺎﻌﻓ ﻢﯿﻘﺗ ﻮھ ﺔﺳارﺪﻟا هﺬھ ﻦﻣ فﺪﮭﻟا)ﺔﯾﻮﻌﻤﻟا نﻮﻟﻮﻘﻟا ﺎﯾﺮﺘﻜﺑ (
فﺮﺷﻻا ﻒﺠﻨﻟا ﺔﻈﻓﺎﺤﻣ ﻲﻓ ﺔﯿﻟﻮﺒﻟا.
ﻞﻤﻌﻟا قﺮط: ﻊﻤﺟ ﻢﺗ٨١ﻜﻟاو نﻮﻟﻮﻘﻟا ﺎﯿﺸﯾﺮﺷا ﺎﯾﺮﺘﻜﺑ ﻦﻋ يﺮﺤﺘﻟا ﻢﺗو  ﺔﯿﻟﻮﺒﻟا يرﺎﺠﻤﻟا بﺎﮭﺘﻟﺎﺑ ﻦﯿﺑﺎﺼﻣ ﻰﺿﺮﻣ ﻦﻣ راردا ﺔﻨﯿﻋ ﻼﯿﺴﺒﻠ
ﺔﯾﻮﯿﺤﻟا تادﺎﻀﻤﻠﻟ تﻻﺰﻌﻟا ﺔﯿﺳﺎﺴﺣ ﺺﺤﻓ ﻢﺗ.
 ﺞﺋﺎﺘﻨﻟا: ﺔﻣوﺎﻘﻤﻠﻟ لﺪﻌﻣ ﻰﻠﻋأ ﺪﺟو)١٠٠٪ (ﻦﯿﻠﺴﯿﺒﻣﻼﻟﻦﯿﺗﻮﻟﺎﻔﯿﺴﻠﻟ ﺔﻟﺪﺘﻌﻣ ﺔﻣوﺎﻘﻤﻟا نﻮﻜﺗ  ﺎﻤﻨﯿﺑ ،ﻦﯿﻠﯿﺴﯿﺴﻛﻮﻣأو.
جﺎﺘﻨﺘﺳﻻا:هﺬھ ﻲﻓ ﺎھرﺎﺒﺘﺧا ﻢﺗ ﻲﺘﻟا يﻮﯿﺤﻟا دﺎﻀﻤﻠﻟ ﺔﻣوﺎﻘﻤﻟا ةدﺪﻌﺘﻣ ﻼﯿﺴﺒﻠﻜﻟا ﺎﯾﺮﺘﻜﺑو نﻮﻟﻮﻘﻟا ﺎﯾﺮﺘﻜﺑ نا ﺪﺟوﺔﺳارﺪﻟا.
Abstract
Background.Resistance to antibiotics arising  in Escherichia coli and Klebseilla species isolates may
complicate therapeutic management of urinary tract infection(UTI) by this organism.
Aim. The aim of this study was to assess antibiotic activity against UTI isolates of E.coli in Al- Najaf
governorate.
Methodology. Atotal of 81 mid –stream urine samples were collected from patient suspected of UTI
and screened for the occurrence of E.coli.
Result. Susceptibility of the isolates to antibiotics was test by standard methods. Highest rate of
resistance (100%) was found toampicillin and amoxicillin, while moderately resistant to cephalothin .
Conclusion.The present study concluded that E.coli resistance to multiple antibiotic were recognized.
Keywords: Urinary tract infection, Escherichia coli , Klebseilla, Resistant to antibiotic.
INTRODUCTION
A UTI is defined as colonization of a pathogen occurring anywhere along
theurinary tract: kidney, ureter, bladder, and urethra. Traditionally, UTIs have
beenclassified by the site of infection (ie, pyelonephritis [kidney], cystitis
[bladder],urethra [urethritis]) and by severity (ie, complicated versus uncomplicated).
Acomplicated UTI describes infections in urinary tracts with structural or functional
abnormalities or the presence of foreign objects, such as an indwelling urethral
catheter. This model does not necessarily reflect clinical management, however. In
children, a simpler and more practical approach is to categorize UTIas a first infection
versus recurrent infection. Recurrent infections can be further subdivided into
unresolved bacteriuria, bacterial persistence, and reinfection.
The recurrence of a UTI may be caused by several reasons. Unresolved
bacteriuriais most commonly caused by inadequate antimicrobial therapy.
Subtherapeuticlevels of the antimicrobial agents may be a result of noncompliance,
malabsorption, suboptimal drug metabolism, and resistant uropathogens
unresponsiveto attempted therapy (1). In these cases, infection typically resolvesafter
altering the therapy according to antimicrobial sensitivities determined by aproper
urine culture.Bacterial persistence and reinfection occur after sterilization of the urine
hasbeen documented. In the case of bacterial persistence, the nidus of infection in the
urinary tract is not eradicated. Characteristically, the same pathogen is documentedon
urine cultures during subsequent episodes of UTI despite negativecultures after
treatment.
The uropathogen frequently resides in a location that isshielded from
antimicrobial therapy. These protected sites are often anatomicabnormalities,
including infected urinary calculi (2), necrotic papillus or foreign objects, such as an
indwelling ureteral stent (3,4)or urethral catheters(5), which once infected may not be
sterilized. Identification of the anatomicabnormality is essential because surgical
intervention (extirpation) may be necessaryto eradicate the source of infection.
E. coli is the most frequent documented uropathogen. Among neonates, UTI
secondary to group B streptococci is more common than in older populations (6). In
immune compromised children and children with indwellingcatheters, Candida may
be isolated from the urine. Nosocomial infectionsare typically more difficult to treat
and are caused by various organisms, including E. coli, Candida, Enterococcus,
Enterobacter, and Pseudomonas (7).
Bacterial clonal studies strongly support entry into the urinary tract by the fecal-
perineal-urethral route with subsequent retrograde ascent into the bladder. Because of
differences in anatomy, girls are at a higher risk of UTI thanboys beyond the first year
of life. In girls, the moist periurethral and vaginal area spromote the growth of
uropathogens. The shorter urethral length increases thechance for ascending infection
into the urinary tract. Once the uropathogenreaches the bladder, it may ascend to the
ureters and then to the kidneys by someas-yet undefined mechanism. Additional
pathways of infection include nosocomial infection through instrumentation,
hematogenous seeding in the setting ofsystemic infection or a compromised immune
system, and direct extensioncaused by the presence of fistulae from the bowel or
vagina(8).
The urinary tract (ie, kidney, ureter, bladder, and urethra) is a closed,
normallysterile space lined with mucosa composed of epithelium known as
transitionalcells. The main defense mechanism against UTI is constant antegrade flow
ofurine from the kidneys to the bladder with intermittent complete emptying of
thebladder via the urethra. This washout effect of the urinary flow usually clears
theurinary tract of pathogens. The urine itself also has specific
antimicrobialcharacteristics, including low urine pH, polymorphonuclear cells, and
Tamm-Horsfall glycoprotein, which inhibits bacterial adherence to the bladder
mucosalwall (9).
UTI occurs when the introduction of pathogens into this space is associatedwith
adherence to the mucosa of the urinary tract. If uropathogens are clearedinadequately
by the washout effect of voiding, then microbial colonizationpotentially develops.
Colonization may be followed by microbial multiplicationand an associated
inflammatory response.Bacteria that cause UTI in otherwise healthy hosts often
exhibit distinctivepropertiesknown as virulence factorsto overcome the normal
defenses ofthe urinary system (10, 11). In serotypes of E coli frequently isolated in
UTI,bacterial adherence to the uroepithelium is enhanced by adhesins, often
fimbriae(pili), which bind to specific receptors of the uroepithelium(12,13).
The interactionof fimbriae with the mucosal receptor triggers internalization of
thebacterium into the epithelial cell, which leads to apoptosis, hyperinfection, and
invasion into surrounding epithelial cells or establishment of a bacterial focus
forrecurrent UTI (14). Uropathogenic strains of E coli have been recognized torelease
toxins, including cytolethal distending toxin, alpha hemolysin, cytotoxicnecrotizing
factor-1, secreted autotransporter toxin that causes cellular lysis, cause cell cycle
arrest, and promote changes in cellular morphology and function(15,16). To promote
survival, various uropathogens possess siderophore systemscapable of acquiring iron,
an essential bacterial micronutrient, from heme(17). Uropathogenic strains of E coli
have a defensive mechanism that consistsof a glycosylated polysaccharide capsule
that interferes with phagocytosis andcomplement-mediated destruction.
The most common form of resistance to β-lactam agents is caused by enzymes
that render molecules inactive by opening the β-lactam ring. In Gram-positive,β-
lactamase is excreted into the medium and therefore destroys the antibiotics
exracellularly (18). In contrast, the β-lactamase of Gram-negative bacteria is located
in the periplasmic space where they attack the antibiotic before it can reach its
receptor site.
METHODOLOGY:
Present study  was carried  out in two hospitals in Najaf(Al-Sadder Teaching
and Al-Zahra Maternity  and children).During the period from July to October 2012, a
total  of  100 urine samples collected ( by mid – strem urine) from patients suspected
to have UTI were culture on blood agar (Hi-media Laboratories, India) and CHROM
agar (Oxoid, France) using standard method. Gram negative rod isolated in significant
counts (>105cfu/ml) in pure culture were included in the study. Identification of
isolates up to the species level was done according to conventional scheme of
MacFaddin ( 19 ) and was confirmed by an additional biochemical test with API20E
miniaturized diagnostic test (Bio Merieux,France).
RESULTS
The present study included a collection of 100 urine samples from two hospitals
in Najaf during the period from July to October, 2012 Out of the 100 samples
processed; 81 (81%) showed significant bacteriuria. A total of 55(67.9%) females and
26 (32%) males had positive urine culture (significant bacteriuria). The bacterial
isolates obtained as a pure and predominant growth from urine samples were only
considered for the present study.
All bacteria isolated in this study were identified based on colonial morphology,
and biochemical reactions according to MacFaddin (2000). The organisms grown on
the culture of all the 81 urine samples with significant bacteriauria were as follows: 43
(53%) isolates of E. coli, 26 (32%) isolates of Klebsiella spp., 8 (9.8%) isolates of
Proteus spp., and 4 (4.9%) isolates of Pseudomonas spp. The frequency of antibiotic
resistance of the 43 E. coli isolates. E. coli isolates (100%) were found to be resistant
to ampicillin and amoxicillin. (94.7%) ofE. coli isolates were highly resistant to
oxacillin, and moderately resistant to cephalothin (22.5%), ciprofloxacin, gentamycin,
trimethoprime (46.5%), nitrofurantoin (44.1%), nalidxic acid (37.2%), cefotaxime
(39.5%), ceftazidime (34.8%), and   chloramphenicol (27.9%). On the other hand, all
E. coli isolates were susceptible to imipenem.
DISCUSSION
Urinary tract infections are the most common type of the clinical disease
produce by the E.coli. The results showed a high incidence of UTI in females than
males. which might be due to variety of factors, such as the close proximity of the
female urethral meatus to the anus (20), and alternations in vaginal microflora that
play a critical role in encouraging vaginal colonization with coliforms which may lead
to UTI (21, 22). (23) Reported that the bladder infections are 14-times more common
in females than males by virtue of the shortened urethra. Moreover, (24) showed that
UTI are more common in females, 40% of women have an episode in their lifetime
when they are sexually active.
Numerous in vitro studies have shown the E. coli and Klebsiella spp. as the
most common causes of UTI (25). All Klebsiella isolates were identified according to,
The development of antibiotics resistance in these isolates is often related to the
overuse and misuse of the antibiotics prescribed. Iraq is one of the developing
countries where antibiotics sold over the counter, an attitude that encourages self-
medication.
In this investigation, the reason of β-lactam resistance of E. coli isolates is
probably due to the production of TEM β-lactamases, which may be genetically
localized on the chromosome or on a plasmid. The TEM-1 is the most commonly
encountered β-lactamase in Gram-negative bacteria; up to 90% of ampicillin
resistance in E. coli is due to the production of TEM-1 (26). Other studies from many
areas reported an increasing resistance of E. coli to ampicillin.
In this investigation, although the β-lactamases undoubtedly play a major role in
the resistance to β-lactam antibiotics, the high ratio of resistance to ampicillin and
amoxicillin was not only attributable to the production of β-lactamase enzymes. The
other mechanisms conferring resistance to these compounds is caused by reducing of
the activity of β-lactam antibiotics in a resistant cell due to many factors such as; the
sensitivity of the antibiotic to β-lactamases, the penetration through the outer
membrane, the affinity for the target (PBPs), the amount of β-lactamase, and the
affinity of the antibiotic for the β-lactamase  . A range of antibiotics have been used
for the treatment of UTI caused by E. coli and K.pneumoniae in Iraq and other
countries. However, the widely spread use of this approach has criticized on the
ground of drug toxicity and the risk of an increase spread of antibiotic resistance (27).
Bacterial resistance to antibiotics is now widespread and possesses serious
clinical threats. The organisms develop resistance to antibiotics by any of the
following mechanisms: selection, mutation, phage transduction, and transference.
Microbial resistance can be either hereditary in the organism or acquired through the
environment. The high resistance in the present study may be due to antibiotic abuse
which leads to development of resistant isolates in Iraq. In agreement with the present
study, (28) found that 56.8% of clinical E. coli isolates in Najaf were resistant to more
than five antimicrobial agents.
CONCLUSION:
The study concludedEscherichia coli and K. pneumoniae were the predominant
species recovered in patients with significant bacteriuria. Most of the test isolates
were resistant to antibiotics, for that reason such organism pose a serious therapeutic
problem in Najaf hospitals.
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